Skip to main content

Table 2 Median Price [the 25th –75th Percentile] of lowest-priced generic diabetes care essential medicines (public health facilities, n = 17; private medicine outlets, n = 26)a

From: Access to essential medicines for diabetes care: availability, price, and affordability in central Ethiopia

List of EMs available in at least four medicine outlets

PHFs

PMOs

Glibenclamide 5 mg tablet

0.49 [0.30–0.75]

0.60 [0.30–3.00]

Metformin 500 mg tablet

0.72 [0.58–2.20]

1.39 [0.58–3.80]

Metformin 850 mg tablet

 

3.50 [1.40–5.33]

Metformin 1000 mg tablet

 

4.50 [3.50–12.50]

Glimepiride 2 mg tablet

4.25 [4.00–5.33]

6.50 [4.00–12.00]

Glimepiride 3 mg tablet

 

9.00 [4.00–13.00]

Glimepiride 4 mg tablet

 

14.0 [9.20–15.00]

Regular Human Insulin

144.50 [125–150]

180 [125–380]

Premixed Insulin 30/70

147.25 [133–150]

150 [133–400]

Isophane Human Insulin

141.70[127.4–184.51]

184.51 [120–400]

Simvastatin 20 mg tablet

3.49 [3.00–4.00]

3.80 [3.00–9.50]

Simvastatin 40 mg tablet

 

4.80 [4.10–24.50]

Atorvastatin 20 mg tablet

3.40 [2.00–4.50]

3.65 [2.00–23.35]

Atorvastatin 40 mg tablet

4.95 [4.80–5.80]

7.75 [4.00–26.50]

Rosuvastatin 10 mg tablet

 

10.18 [10.0–12.0]

Rosuvastatin 20 mg tablet

 

16.95 [15.50–18.50]

Losartan 50 mg tablet

 

9.80 [8.36–11.80]

Enalapril 5 mg tablet

0.93 [0.60–2.55]

1.00 [0.60–4.30]

Enalapril 10 mg tablet

1.33 [1.00–1.70]

1.50 [1.00–7.50]

Hydrochlorothiazide 25 mg tablet

0.50 [0.35–1.30]

1.20 [0.35–2.5]

Lisinopril 10 mg tablet

 

10.10 [1.80–13.00]

Lisinopril 20 mg tablet

4.25 [2.10–110]

13.50 [2.10–17.00]

Acetylsalicylic acid 81 mg tablet

0.80 [0.45–3.05]

2.50 [0.45–3.50]

Nifedipine 20 mg tablet

0.78 [0.60–1.70]

1.00 [0.50–9.80]

Amlodipine 5 mg tablet

0.95 [0.50–1.50]

1.20 [0.50–7.80]

Amlodipine 10 mg tablet

1.60 [1.00–2.30]

2.00 [1.00–12.20]

Overall median price

1.60 [0.3–184.51]

4.65 [0.30–400.0]

  1. aMedian Price Ratio (MPR) for international price comparison were not reported in this study as MSH 2015 international price reference (IPR) guideline was outdated to use. Therefore, the study took Health Action International’s recommendation to present the price outcome by median price in the local currency, ETB (0.0203 USD)